WO2003065044A8 - Diagnostics and therapeutics for diseases associated with gpr72 - Google Patents
Diagnostics and therapeutics for diseases associated with gpr72Info
- Publication number
- WO2003065044A8 WO2003065044A8 PCT/EP2003/000476 EP0300476W WO03065044A8 WO 2003065044 A8 WO2003065044 A8 WO 2003065044A8 EP 0300476 W EP0300476 W EP 0300476W WO 03065044 A8 WO03065044 A8 WO 03065044A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- disorders
- diseases
- gpr72
- nervous system
- therapeutics
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003205627A AU2003205627A1 (en) | 2002-02-01 | 2003-01-20 | Diagnostics and therapeutics for diseases associated with gpr72 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02001941.0 | 2002-02-01 | ||
EP02001941 | 2002-02-01 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2003065044A2 WO2003065044A2 (en) | 2003-08-07 |
WO2003065044A8 true WO2003065044A8 (en) | 2003-12-24 |
WO2003065044A3 WO2003065044A3 (en) | 2004-03-04 |
Family
ID=27635779
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2003/000476 WO2003065044A2 (en) | 2002-02-01 | 2003-01-20 | Diagnostics and therapeutics for diseases associated with gpr72 |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003205627A1 (en) |
WO (1) | WO2003065044A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1941282A1 (en) * | 2005-09-19 | 2008-07-09 | Eisai R&D Management Co., Ltd. | Methods for identifying gpr83 agonists and antagonists capable of modulating regulatory t cell function |
CA2589393C (en) | 2006-06-13 | 2016-04-12 | Euroscreen S.A. | Ligand for g-protein coupled receptor gpr72 and uses thereof |
EP1867994B1 (en) * | 2006-06-13 | 2012-09-26 | Euroscreen S.A. | Ligand for G-protein coupled receptor GPR72 and uses thereof |
US20090280092A1 (en) * | 2007-01-22 | 2009-11-12 | Wiebke Hansen | G-Protein Coupled Receptor 83 As a Molecular Switch for the Induction of Regulatory (immunosuppressive) T-cells |
US8557533B2 (en) | 2007-02-01 | 2013-10-15 | Helmut Jonuleit | Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1165147A (en) * | 1996-02-07 | 1997-11-19 | 武田药品工业株式会社 | Guanine nudeotide combined protein coupled receptor proteins, their production and use |
CA2231754A1 (en) * | 1997-05-07 | 1998-11-07 | Smithkline Beecham Corporation | A novel human g-protein coupled receptor hcept09 |
SE9904660D0 (en) * | 1999-12-17 | 1999-12-17 | Astra Pharma Inc | Novel assays |
-
2003
- 2003-01-20 WO PCT/EP2003/000476 patent/WO2003065044A2/en not_active Application Discontinuation
- 2003-01-20 AU AU2003205627A patent/AU2003205627A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2003205627A1 (en) | 2003-09-02 |
WO2003065044A3 (en) | 2004-03-04 |
WO2003065044A2 (en) | 2003-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003082314A3 (en) | Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) | |
WO2003081258A3 (en) | Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs) | |
WO2003074069A3 (en) | Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1) | |
WO2004042389A3 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4d (pde4d) | |
WO2005106491A3 (en) | Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase 1 (sgk1) | |
WO2003093816A3 (en) | Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr) | |
WO2003065044A8 (en) | Diagnostics and therapeutics for diseases associated with gpr72 | |
WO2004042402A3 (en) | Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1) | |
WO2003095967A3 (en) | Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9) | |
WO2004071378A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) | |
WO2004038405A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43) | |
WO2003083135A3 (en) | Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2) | |
WO2003066077A3 (en) | Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) | |
WO2004071394A3 (en) | Diagnostics and therapeutics for diseases associated with hm74 | |
WO2003100433A3 (en) | Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 3 (avpr3) | |
WO2003096020A3 (en) | Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8) | |
WO2004038421A3 (en) | Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 41 (gpr41) | |
WO2003081257A3 (en) | Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 1 (npff1) | |
WO2003081256A3 (en) | Diagnostics and therapeutics for diseases associated with human g protein-coupled orphan receptor 21 (gpr21) | |
WO2003100435A3 (en) | Diagnostics and therapeutic use of neuromedin u receptor 2 (nmu2) | |
WO2004042405A3 (en) | Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 3 (gpr3) | |
WO2003100434A3 (en) | Diagnostic and therapeutic use of the arginine vasopressin receptor 2 (avpr2) | |
WO2003100436A3 (en) | Diagnostics and therapeutics for diseases associated with chemokine receptor 10 (ccr10) | |
WO2004071392A8 (en) | Diagnostics and therapeutics for diseases associated with acetylcholine receptor, muscarinic 4(m4) | |
WO2003087843A3 (en) | Diagnostics and therapeutics for diseases associated with mas related gene f (mrgf) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: IN PCT GAZETTE 32/2003 UNDER (22) REPLACE "2 JANUARY 2003 (02.01.2003)" BY "20 JANUARY 2003 (20.01.2003)" |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase in: |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |